How should I structure and present a long case on chronic suppurative otitis media (CSOM) for my ENT exit examination?

CSOM Long Case Presentation Structure for ENT Exit Exam

For your ENT exit examination, structure your CSOM long case presentation systematically around the definition, clinical assessment, complications, and management algorithm, emphasizing the chronic inflammation with tympanic membrane perforation and persistent discharge as the core pathology.

Definition and Classification

Begin by defining CSOM precisely: chronic inflammation of the middle ear and mastoid mucosa with a non-intact tympanic membrane (perforation or ventilation tube) and persistent ear discharge 1. Note that there is no universal consensus on duration—recommendations range from 2 weeks to at least 3 months of discharge 1. The WHO requires 14 days while most otologists require 2-3 months 2.

Key Classification Points:

• Tubotympanic (safe) type: Central perforation, mucosal disease
• Atticoantral (unsafe) type: Attic/marginal perforation, often with cholesteatoma
• Distinguish from acute otitis media (AOM) and otitis media with effusion (OME) which have intact tympanic membranes 3

Clinical Presentation

Primary Symptoms:

• Persistent ear discharge (otorrhoea)—the hallmark feature
• Hearing loss—conductive type, averaging 25 decibels 4
• Duration of symptoms (critical for diagnosis)

History Taking Essentials:

• Duration and character of discharge: Mucopurulent versus foul-smelling (suggests cholesteatoma)
• Hearing impairment: Onset, progression, bilateral versus unilateral
• Otalgia: Usually absent unless complications present
• Previous episodes: Recurrent acute otitis media history
• Risk factors: Poor socioeconomic conditions, lack of healthcare access 5, immunocompromise
• Complications screening: Headache, vertigo, facial weakness, fever (red flags for intracranial extension) 6

Physical Examination Focus:

• Otoscopy findings:
  • Tympanic membrane perforation (location, size)
  • Character of discharge
  • Granulation tissue or polyps
  • Cholesteatoma (white debris in attic)
  • Condition of middle ear mucosa
• Tuning fork tests: Rinne and Weber to confirm conductive hearing loss
• Cranial nerve examination: Especially facial nerve (CN VII)
• Mastoid examination: Tenderness, postauricular swelling
• Fistula test: For labyrinthine involvement

Investigations

Essential Workup:

• Pure tone audiometry: Document degree and type of hearing loss
• Tympanometry: Typically flat tracing with perforation 3, 7
• Ear swab for culture and sensitivity: Critical for antibiotic selection, especially with treatment failure 8
• High-resolution CT temporal bone:
  • For surgical planning
  • To identify cholesteatoma
  • To assess ossicular chain
  • To detect complications (mastoiditis, intracranial extension) 9, 6

Complications Assessment

CSOM can lead to life-threatening complications, particularly in developing countries where it remains a leading cause of hearing loss and mortality 1.

Extracranial Complications:

• Mastoiditis
• Facial nerve palsy
• Labyrinthitis
• Subperiosteal abscess

Intracranial Complications (Medical Emergencies):

• Meningitis
• Brain abscess (temporal lobe or cerebellar) 6
• Lateral sinus thrombosis
• Extradural abscess

Common pitfall: In developing countries, 89.3% of admitted CSOM cases present with complications 5. Always maintain high suspicion and low threshold for imaging.

Management Algorithm

Initial Conservative Management:

Step 1: Aural Toileting (Essential First Step)

• Dry mopping or suction clearance of discharge
• This is fundamental to all subsequent treatment 10, 11

Step 2: Topical Antibiotic Therapy

Topical quinolones (ciprofloxacin or ofloxacin) are the first-line treatment for CSOM 10, 12. The evidence shows:

• Quinolones versus aminoglycosides: Quinolones may have higher resolution rates (RR 1.92), though evidence is very uncertain 10
• Quinolones versus boric acid: Quinolones likely increase resolution at 1-2 weeks (RR 1.86, moderate-certainty evidence), with one additional person achieving dry ear for every four treated 12
• Topical antibiotics with systemic antibiotics: May increase resolution compared to systemic alone (RR 1.47) 10

Avoid aminoglycosides when possible due to ototoxicity risk, particularly with exposed middle ear structures 10.

Topical Antiseptics:

Boric acid in alcohol with dry mopping may help resolution compared to dry mopping alone (RR 1.73), though evidence is very uncertain 11. Acetic acid may be as effective as aminoglycosides 12.

Systemic Antibiotics:

The evidence for systemic antibiotics alone is very limited 13. When topical antibiotics are used, adding oral antibiotics may provide little additional benefit (RR 1.05 for resolution) 13. Reserve systemic antibiotics for:

• Suspected complications
• Failed topical therapy
• Extensive disease

Treatment Duration:

• Minimum 2 weeks of topical therapy
• Continue until dry ear achieved
• Monitor for recurrence

Surgical Management Indications:

Consider surgery when:

• Medical management fails after adequate trial (6-12 weeks)
• Cholesteatoma present
• Complications develop
• Persistent perforation after infection control
• Significant hearing loss requiring reconstruction

Surgical Options:

• Tympanoplasty: For dry perforation repair
• Mastoidectomy: For mastoid disease, cholesteatoma 8
• Tympanomastoidectomy: Combined approach for extensive disease 8
• Ossiculoplasty: For hearing reconstruction

Quality of Life and Prognosis

CSOM significantly impacts physical, social, and psychological well-being 14. The global prevalence of OM-associated hearing loss is 30 per 10,000 individuals 1.

Follow-up Strategy:

• 6-month evaluation post-treatment to assess recovery 14
• Audiometric reassessment
• Otoscopic examination for perforation status
• Screen for recurrence

Long-term Sequelae:

• Permanent hearing loss
• Tympanic membrane changes (myringosclerosis, atrophy)
• Persistent perforation (2% with ventilation tubes) 3
• Cholesteatoma development

Common Pitfalls to Avoid

1. Misdiagnosis: Distinguish CSOM from acute otitis media with perforation, otitis externa, or malignancy
2. Inadequate aural toileting: Cannot assess tympanic membrane or deliver topical therapy effectively without clearing discharge
3. Delayed imaging: Missing intracranial complications, particularly in resource-limited settings 6, 5
4. Ototoxic medications: Avoid aminoglycosides when safer alternatives available
5. Premature surgery: Ensure adequate medical management trial first
6. Ignoring underlying causes: Dental abscess can cause CSOM 9—consider atypical sources if refractory
7. Antibiotic resistance: Culture-guided therapy essential, especially with treatment failure 8

Examination Presentation Tips

• Present chronologically: History → Examination → Investigations → Diagnosis → Management
• Emphasize morbidity (hearing loss, QOL impact) and mortality (intracranial complications)
• Demonstrate understanding of evidence hierarchy: Guidelines show topical quinolones preferred over aminoglycosides
• Discuss both conservative and surgical options with clear indications
• Address complications systematically—examiners expect thorough knowledge of life-threatening sequelae